Literature DB >> 20803557

A sequential Cox approach for estimating the causal effect of treatment in the presence of time-dependent confounding applied to data from the Swiss HIV Cohort Study.

Jon Michael Gran1, Kjetil Røysland, Marcel Wolbers, Vanessa Didelez, Jonathan A C Sterne, Bruno Ledergerber, Hansjakob Furrer, Viktor von Wyl, Odd O Aalen.   

Abstract

When estimating the effect of treatment on HIV using data from observational studies, standard methods may produce biased estimates due to the presence of time-dependent confounders. Such confounding can be present when a covariate, affected by past exposure, is both a predictor of the future exposure and the outcome. One example is the CD4 cell count, being a marker for disease progression for HIV patients, but also a marker for treatment initiation and influenced by treatment. Fitting a marginal structural model (MSM) using inverse probability weights is one way to give appropriate adjustment for this type of confounding. In this paper we study a simple and intuitive approach to estimate similar treatment effects, using observational data to mimic several randomized controlled trials. Each 'trial' is constructed based on individuals starting treatment in a certain time interval. An overall effect estimate for all such trials is found using composite likelihood inference. The method offers an alternative to the use of inverse probability of treatment weights, which is unstable in certain situations. The estimated parameter is not identical to the one of an MSM, it is conditioned on covariate values at the start of each mimicked trial. This allows the study of questions that are not that easily addressed fitting an MSM. The analysis can be performed as a stratified weighted Cox analysis on the joint data set of all the constructed trials, where each trial is one stratum. The model is applied to data from the Swiss HIV cohort study.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20803557     DOI: 10.1002/sim.4048

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  23 in total

Review 1.  Big data in medical science--a biostatistical view.

Authors:  Harald Binder; Maria Blettner
Journal:  Dtsch Arztebl Int       Date:  2015-02-27       Impact factor: 5.594

2.  Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies.

Authors:  Mohammad Ehsanul Karim; Paul Gustafson; John Petkau; Helen Tremlett
Journal:  Am J Epidemiol       Date:  2016-07-25       Impact factor: 4.897

3.  Comparison of statistical approaches dealing with time-dependent confounding in drug effectiveness studies.

Authors:  Mohammad Ehsanul Karim; John Petkau; Paul Gustafson; Robert W Platt; Helen Tremlett
Journal:  Stat Methods Med Res       Date:  2016-09-21       Impact factor: 3.021

4.  Nephrology consultation and mortality in people with stage 4 chronic kidney disease: a population-based study.

Authors:  Ping Liu; Robert R Quinn; Mohammad Ehsanul Karim; Aminu Bello; Helen Tam-Tham; Robert Weaver; Paul E Ronksley; Hude Quan; Giovanni F M Strippoli; Braden Manns; Brenda R Hemmelgarn; Marcello Tonelli; Pietro Ravani
Journal:  CMAJ       Date:  2019-03-11       Impact factor: 8.262

5.  Re-Treatment after Ureteroscopy and Shock Wave Lithotripsy: A Population Based Comparative Effectiveness Study.

Authors:  Diana K Bowen; Lihai Song; Jen Faerber; John Kim; Charles D Scales; Gregory E Tasian
Journal:  J Urol       Date:  2020-03-24       Impact factor: 7.450

6.  Modeling survival distribution as a function of time to treatment discontinuation: A dynamic treatment regime approach.

Authors:  Shu Yang; Anastasios A Tsiatis; Michael Blazing
Journal:  Biometrics       Date:  2018-01-22       Impact factor: 2.571

7.  Effect of oral anticoagulant therapy on mortality in end-stage renal disease patients with atrial fibrillation: a prospective study.

Authors:  Simonetta Genovesi; Paola Rebora; Maurizio Gallieni; Andrea Stella; Fabio Badiali; Ferruccio Conte; Sonia Pasquali; Silvio Bertoli; Patrizia Ondei; Giuseppe Bonforte; Claudio Pozzi; Emanuela Rossi; Maria Grazia Valsecchi; Antonio Santoro
Journal:  J Nephrol       Date:  2016-11-11       Impact factor: 3.902

8.  Marginal structural Cox models for estimating the association between β-interferon exposure and disease progression in a multiple sclerosis cohort.

Authors:  Mohammad Ehsanul Karim; Paul Gustafson; John Petkau; Yinshan Zhao; Afsaneh Shirani; Elaine Kingwell; Charity Evans; Mia van der Kop; Joel Oger; Helen Tremlett
Journal:  Am J Epidemiol       Date:  2014-06-17       Impact factor: 4.897

9.  Recurrent event frailty models reduced time-varying and other biases in evaluating transfusion protocols for traumatic hemorrhage.

Authors:  Sangbum Choi; Mohammad H Rahbar; Jing Ning; Deborah J Del Junco; Elaheh Rahbar; Chuan Hong; Jin Piao; Erin E Fox; John B Holcomb
Journal:  J Clin Epidemiol       Date:  2016-04-29       Impact factor: 6.437

10.  Resuscitate early with plasma and platelets or balance blood products gradually: findings from the PROMMTT study.

Authors:  Deborah J del Junco; John B Holcomb; Erin E Fox; Karen J Brasel; Herb A Phelan; Eileen M Bulger; Martin A Schreiber; Peter Muskat; Louis H Alarcon; Mitchell J Cohen; Bryan A Cotton; Charles E Wade; John G Myers; Mohammad H Rahbar
Journal:  J Trauma Acute Care Surg       Date:  2013-07       Impact factor: 3.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.